3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 3
2
Phase 2
2
Phase 2/3
1
Phase 1
1
Status
Withdrawn
2
Completed
2
Unknown
1
Suspended
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
592
Neoplasms
296
Carcinoma, Non-Small-Cell Lung
284
Prostatic Neoplasms
266
Colorectal Neoplasms
213
Multiple Myeloma
181
Lung Neoplasms
149
Neoplasm Metastasis
139
Leukemia, Myeloid, Acute
125
Leukemia
120
Lymphoma
114
Lymphoma, Follicular
113
Stomach Neoplasms
105
Lymphoma, Non-Hodgkin
102
Colonic Neoplasms
98
Ovarian Neoplasms
96
Rectal Neoplasms
95
Precursor Cell Lymphoblastic Leukemia-Lymphoma
94
Uterine Cervical Neoplasms
93
Head and Neck Neoplasms
92
Leukemia, Lymphocytic, Chronic, B-Cell
91
Pain
90
Carcinoma, Hepatocellular
86
Pancreatic Neoplasms
81
Melanoma
78
Lymphoma, Large B-Cell, Diffuse
77
Papillomavirus Infections
68
Recurrence
66
Squamous Cell Carcinoma of Head and Neck
64
Parkinson Disease 4, Autosomal Dominant Lewy Body
62
Interventions
Ketamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
Pain, Intractable
×
Clear all
NCT01326325
2013-08-07
KEPAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
24 enrolled
NCT00484484
2011-05-04
KETADOL
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
100 enrolled